trial

Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation

NCTId NCT05667961
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 480 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2025-01-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
480 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2022-09-15
Primary completion
2025-01-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
—

Sponsors

Shanghai Mental Health CenterLead Sponsor
Merck Sharp & Dohme LLCCollaborator

Investigators

1
Dengtang Liu, MDPrincipal Investigator

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
480
Phase
NA
Primary Completion Date
2025-01-31
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Shanghai Mental Health Center
company
collaborator
Merck Sharp & Dohme LLC
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Dengtang Liu, MD
person